Michael J. Fox Foundation for Parkinson’s Research: Mitochondrial Biomarkers for Parkinson’s Disease

The specific goals of this initiative are to facilitate the discovery and development of mitochondrial biomarkers to:

  • assess PD diagnosis, disease progression, and/or patient stratification;
  • identify mitochondrial readouts that would inform therapeutic efficacy and target engagement; or
  • uncover novel mitochondrial targets relevant to Parkinson’s Disease.

Funding & Duration

This funding mechanism has a budget maximum of US $200,000 (approx AUD $252,000) and the requested funding support should be commensurate with the stage of development and work proposed.

Investigators may request support for a one-to-two year research plan and should include a timeline with the pre-proposal.

MJFF policy is that no more than 25% (non-profit institutions) or 10% (for-profit organisations) of the direct costs may go to indirect costs.


Applications may be submitted by:

  • U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities;
  • U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments, and eligible agencies of the federal government.

Post-doctoral fellows are NOT eligible to apply as principal investigators to this program.

Submission Requirements & Due Dates

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences. Bookmark the permalink.

Comments are closed.